In this segment of Pharmaceutical Executive’s video interview, Cellarity’s CEO, Fabrice Chouraqui, explains what makes the company’s AI/ML approach different and the benefits it brings in terms of discovering new therapeutic opportunities.
What makes Cellarity’s AI/ML approach different?
Leave a comment
